Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| UL1TR001082 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The role of oxidative stress in disease pathology is increasingly recognized. At present, the development of biomarkers of this state is in its infancy and the availability of clinically validated assays is lacking. This study will better determine normal values for specific biomarkers of oxidative stress. It will also investigate normal values of taurine, a natural occurring oxidative stress protectant. A primary and specific application of this data is for the evaluation of oxidative stress, levels of the natural protectant taurine, and of associated inflammation in the context of cystathionine β-synthase (ClinicalTrials.gov study: Oxidative Stress Markers in Inherited Homocystinuria and the Impact of Taurine).
This study is a one-time collection of blood and urine samples in healthy individuals. Subjects have to be fasting for 3 hours prior to the blood sampling. A maximum of 7.5 mLs of blood (1 and 1/5 teaspoon) and a urine sample will be collected.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Oxidative stress marker: TBARS | Single Draw for one-time analysis | Time 0 |
| Metabolite antioxidant: Taurine | Single Draw for one-time analysis | Time 0 |
| Measure | Description | Time Frame |
|---|---|---|
| Inflammation marker: Supper oxide dismutase (SOD) | Single Draw for one-time analysis | Time 0 |
| Inflammation marker: TGFβ | Single Draw for one-time analysis |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Pregnancy: Females who are pregnant or lactating will be excluded from the study as the influence of pregnancy on the markers is not known nor is the impact of pregnancy on taurine known.
Antioxidant use: Individuals taking taurine, over the counter energy drinks containing taurine or other high dose antioxidants such as Vitamin C or E, coenzyme Q, carotenes, selenium will be excluded as such intake will likely impact laboratory results.
Inflammatory status:
Not provided
Not provided
Healthy Individuals older than 8 years and less than 50 years
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Johan LK Van Hove, MD, PhD, MBA | University of Colorado, Denver | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Children's Hospital Colorado | Aurora | Colorado | 80045 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Time 0 |
| Inflammation marker: myeloperoxidase | Single Draw for one-time analysis | time 0 |
| Metabolites: S-adenosylmethionine and S-adenosylhomocysteine | Single Draw for one-time analysis (same units) | Time 0 |
| Vascular function: Thromboxane B2 metabolites | Single Draw for one-time analysis (same units) | Time 0 |
| Oxidative stress: dityrosine | Single Draw for one-time analysis | Time 0 |
| Inflammation markers: IL1α, IL-1β, IL10, TNFα | Single Draw for one-time analysis; ELISA assay (same units) | Time 0 |
| Inflammation markers: cytokines: IL1α, IL-1β IL-1ra, IL6, IL8, IL17, MCP-1,MIP-1, MIP1α, MIPβ | Single Draw for one-time analysis; Luminex assay (same units) | Time 0 |
| Inflammation markers: cytokines: TNFα, IL4, IL10 and IL12 | Single Draw for one-time analysis; high sensitivity Luminex assay (same units) | Time 0 |
| Inflammation marker: high sensitivity CRP | Single Draw for one-time analysis | Time 0 |